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Abstract
Aim. The number of patients with endocrine disorders in the world, in particular, Graves’ disease is continuously increas-
ing. Recent studies have determined the fact of insulin resistance in thyroid disorders. On the one hand, numerous researches prove 
correlation of hypothyroidism with arterial hypertension, ischaemic heart disease and lipid metabolism disorder, on the other – car-
bohydrate metabolism disorder and hyper-sympathicotonia are closely associated with hyperthyroidism. The subject of the research 
was to study the correlation of insulin resistance, lipid and carbohydrate metabolism indices in patients with Graves’disease. 
Material and Methods. During the study 53 (37 female and 16 male) patients with Graves’ disease with noticed IR have 
been examined. At the beginning, after 3- and 6-months thyreostatic therapy with insulin sensitizers (metformin or pioglitazone) 
the following investigations have been performed: assessing thyroid-stimulating hormone levels, free thyroxine and triiodothy-
ronine; assessing glycated haemoglobin, glucose, C-peptide and fasting insulin as primary IR markers; calculating НОМА-IR in-
dex for analysing tissue sensitivity to insulin; calculating НОМА-β index for evaluating the functional capacity of β-cells of islets 
of Langerhans; measuring Caro indices to monitor hyperinsulinemia, measuring total cholesterol level, low-density lipoproteins, 
very-low-density lipoproteins, high-density lipoproteins , triglycerides, for analysing IR in relation to lipid metabolism.
Results. The research results found out that free thyroid hormones and thyroid-stimulating hormone are closely related to 
lipid metabolism. Thus, thyroid-stimulating hormone was characterized as having direct correlation with low-density lipoproteins, 
while the free thyroxine inversely correlated with total cholesterol, low-density lipoproteins, and high-density lipoproteins. The 
free triiodothyronine negatively correlated with high-density lipoproteins. The research has also determined the direct correlation 
between insulin and free thyroxine, as well as free triiodothyronine in patients with diffuse toxic goitre. 
Conclusions. The study proves the presence of insulin resistance in patients with Graves’ disease that generates interest to 
further study of the changes in insulin sensitivity, relation of insulin resistance to thyroid-stimulating hormone, thyroid hormones 
and looking for the ways to correct these disorders.
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1. Introduction
The number of patients with endocrine disorders in the world, in particular, Graves’ dis-
ease is continuously increasing [1, 2]. For the last 5 years, the incidence of endocrine disorders in 
Ukraine has increased by 13 % and the number of patients registered with thyrotoxicosis annually 
increases by 5 %, which is significantly higher than the world and European indices [3].
Original Research Article:
full paper




H. P. Hirnsworth and R. B. Kerr were the first to use the term “insulin resistance” in 1939. 
By “insulin resistance” (IR) we traditionally mean the altered tissue response to endogenous insu-
lin, that is manifested by impaired glucose uptake in the adipose tissue and skeletal muscles, as well 
as suppression of hepatic gluconeogenesis [4]. Recent studies show that we can recognize IR not 
only in the pathogenesis of type 2 diabetes mellitus but also in many other pathological conditions, 
such as polycystic ovary syndrome, arterial hypertension, atherosclerosis, non-alcoholic steatohep-
atitis, etc. Thus, we can also observe the insulin resistance in thyroid disorders. On the one hand, 
numerous researches prove the correlation of hypothyroidism with arterial hypertension, ischaemic 
heart disease and lipid metabolism disorder, on the other – carbohydrate metabolism disorder and 
hyper-sympathicotonia are closely associated with hyperthyroidism [5]. 
Clinical and experimental studies have found out that in thyrotoxicosis insulin interacts dif-
ferently with its target tissues (liver, muscles, adipose tissue, and endothelium) [6–8]. In particular, 
it has been found out that the frequency and degree in glucose intolerance like β-cells of the islets of 
Langerhans dysfunction highly depended on the severity of the clinical course of Graves’disease [9].
In Graves’ disease there develops hepatic insulin resistance, accompanied by the increased 
fasting plasma glucose, increased endogenous glucose production by the liver due to the increased 
availability of gluconeogenesis precursors and glycogenolysis activation [10]. Several researchers 
pointed out that both thyroxine and insulin stimulate the expression of hexokinase and glycogen 
synthetase, which are responsible for the glucose absorption and disposal by the formation of glu-
cose 6-phosphate and glucose-1 phosphate [11, 12]. Researches at the molecular level revealed that 
most of the rat liver enzymes, involved in gluconeogenesis are regulated by thyroid hormones [13].
The influence of thyroid hormones on glucose regulation is associated with the changes in 
insulin secretion and hormone antagonists of insulin, glucose absorption in the intestine and its 
utilization by adipose and muscle tissues, stimulation of gluconeogenesis in the liver [14, 15]. There 
are evidences that triiodothyronine is able to enhance glucose metabolism in the liver by the action 
on the hypothalamic and pituitary system. This effect is realized through sympathetic fibers in-
volved in innervation of hepatocytes and does not depend on the level of thyroid hormones, insulin 
and corticosteroid content in the blood [16].
2. Aim of the research 
To find out the correlation between insulin resistance, carbohydrate and lipid metabolism 
indices in patients with Graves’ disease. 
3. Materials and methods
During the study 53 (37 female and 16 male) 42,0±0,9 years, patients with Graves’disease 
with noticed IR have been examined. At the beginning, after 3- and 6-months thyreostatic ther-
apy with insulin sensitizers (metformin or pioglitazone) the following investigations have been 
performed: assessing thyroid-stimulating hormone levels (TSH), free thyroxine (FТ4) and triiodo-
thyronine (FТ3); assessing glycated haemoglobin (HbA1c), glucose, C-peptide and fasting insulin 
as primary IR markers; calculating НОМА-IR index for analysing tissue sensitivity to insulin; 
calculating НОМА-β index for evaluating the functional capacity of β-cells of islets of Langerhans; 
measuring Caro indices to monitor hyperinsulinemia, measuring total cholesterol level, low-den-
sity lipoproteins (LDL), very-low-density lipoproteins (VLDL), high-density lipoproteins (HDL), 
triglycerides (TG), for analysing IR in relation to lipid metabolism. 
Functional condition of thyroid was evaluated by determining the basal serum concentra-
tions of TSH, FT4 and FT3 of patients, using enzyme-linked immunosorbent assay (ELIZA) with 
the help of test-system of company Roche Diagnostics (Switzerland) on automatic analyzer Cobas 
6000 (e 601 module). 
The content of blood glucose was determined by oxidase method, the level of HbA1c immu-
noturbidity method, cholesterol and his fractions were defined by enzymatic-spectrophotometric 
method. Quantitative determination of immunoreactive insulin in the serum of venous blood was 
carried out with the help of analyzer Cobas 6000(e 601 module) using test-system Roche Diagnos-
tics (Switzerland), based on electro-chemiluminescence immunoassay (ECLIA). For the determi-
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nation the C-peptide a two-step immune-chemiluminescence analysis (CLIA) using the analyzer 
Liaison and test strips to DiaSorin (Italy) was applied. 
Statistical analysis was performed on the PC using Microsoft Excel (USA) and STATISTICA 6.0. 
(“Statsoft”, USA) software [17].
The study was performed using variational statistics and statistical coefficients. The as-
sessment of normal distribution of index changes has been done using the Shapiro-Wilk test. The 
results are represented by arithmetic mean (M), its standard errors (σ) for absolute values, and the 
average error (m) for relative values.
The correlation analysis was performed for all the studied indices. The r-value (linear cor-
relation coefficient) (r) and its probabiity (p) have been measured and shown in tables.
R-value was estimated as probable in the case when p<0.05. While using r-value (r) we can 
also observe the direction of correlation (direct +, inverse –) and the strength of correlation (0–1). 
When r=0, there is considered as no correlation, 0–0.3 indicates low correlation, 0.3–0.7 shows 
association of medium strength, 0.7–1.0 represents strong correlation. The Pearson’s correlation 
method is regarded as the most accurate method of studying correlation. The probable deviation or 
relationship between groups was represented by statistically significant coefficient (p<0.05). 
While conducting the clinical trial we followed issues highlighted in The Helsinki Declara-
tion of Human Rights, The European Convention on Human Rights and Biomedicine, and relevant 
laws of Ukraine and focused on patients’ health safety, protection of patients’ rights, human digni-
ty, as well as moral and ethical standards.
4. Results 
We could observe few correlations in patients with Graves’ disease, who were involved in 
the study. Such interactions as TSH – FТ4 (r=–0,844; р<0,001), TSH – FТ3 (r =–0,655; р<0,001), 
FТ4–FТ3 (r=0,600; р<0,001), fasting glucose – HbA1c (r=0,704; р<0,001), insulinglucose – 
HbA1cНОМА-IR (r =0,971; р<0,001), insulin – НОМА-β (r =0,736; р<0,001) were likely to happen. 
Correlation data analysis in patients with Graves’ disease found out a few low- and medi-
um-strenght correlations of lipid metabolism (Table 1). The following fact has been noticed: TSH 
directly correlated with LDL (r=0,201), on the contrary FТ4 inversely correlated with the free 
cholesterol (r=–0,267), LDL (r=–0,241), and HDL (r=–0,209). Free T3 negatively correlated with 
HDL (r=–0,254) and did not show any other probable correlations. 
Table 1




Total Cholesterol r=0,233 r=–0,267* r=–0,184
HDL r=0,165 r=–0,209 r=–0,254*
LDL r=0,201# r=–0,241* r=–0,138
VLDL r=0,175 r=–0,124 r=–0,143
TG r=–0,037 r=0,068 r=0,081
Note: * – probable mean error (р<0,05); # – tendency to probable mean errors (0,05<р<0,1)
Specifics of correlations in carbohydrate metabolism is demonstrated in Table 2. Fasting 
glucose directly correlated with HbA1c (r=0,704), НОМА-IR (r=0,522), insulin (r=0,322) and in-
versely correlated with HDL (r=–0,203). So, HbA1c also directly correlated with glucose (r=0,704), 
НОМА-IR (r=0,460) and inversely correlated with the free cholesterol (r=–0,202), HDL (r=–0,257). 
The insulin level directly correlated with FТ4 (r=0,211), FТ3 (r=0,277), glucose (r=0,322), HbA1c 
(r=0,338) and inversely correlated with HDL (r=–0,309). While determining the correlations be-
tween indices, we noted low direct correlation between C-peptide and TG (r=0,234, р<0,05), that 
had never been noticed before.
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Correlation relationships in patients with Graves’ disease
Index
Correlation
Glucose HbA1c C-peptide Insulin
ТТГ r=0,035 r=–0,063 r=–0,122 r=–0,172
FТ4 r=0,075 r=0,184 r=0,123 r=0,211#
FТ3 r=0,084 r=0,139 r=0,042 r=0,277*
Glucose r=0,704* r=–0,007 r=0,322*
HbA1c r=0,704* r=0,132 r=0,338*
C-peptide r=–0,007 r=0,132 r=–0,109
Insulin r=0,322* r=0,338 r=–0,109
Total Cholesterol r=–0,096 r=–0,202# r=0,147 r=–0,122
HDL r=–0,203# r=–0,257* r=0,082 r=–0,309*
LDL r=–0,085 r=–0,156 r=0,142 r=–0,065
VLDL r=0,047 r=–0,147 r=0,049 r=–0,116
TG r=–0,003 r=0,184 r=0,234* r=0,159
Note: * – probable mean error (р<0,05). # – tendency to probable mean errors (0,05<р<0,1)
Table 3 demonstrates correlations of two IR indices: НОМА-IR and НОМА-β. Besides 
mentioned correlations НОМА-IR-HbA1c, НОМА-IR – glucose we can also observe direct cor-
relations of HOMA-IR index with вТ4 (r=0,22), вТ3 (r=0,267), insulin (r=0,971) and inverse cor-
relation HDL (r=–0,321). These observations correspond to other studies, which found out that 
HOMA-IR index and insulin positively correlate with вТ3 і вТ4 in patients with Graves’ disease 
[18]. We obtained the direct correlation between НОМА-β index and insulin (r=0,736) and in-
verse correlation with glucose (r=–0,36). We were the first to note the inverse association between 
НОМА-IR indices and Caro index (r=–0,764). We consider this correlation to be logical as de-
creased Caro index defines hyperinsulinemia, which causes the increase of IR by НОМА-IR data 
and is associated with β-cells function defects.
Table 3









Caro index r=–0,764* r=–0,817
HDL r=–0,321* r=–0,181
Note: * – probable mean error (р<0,05). # – tendency to probable mean errors (0,05<р<0,1)
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The results of the research found out that free thyroid hormones and thyroid-stimulating 
hormone (TSH) are closely related to lipid metabolism. Thus, TSH was characterized as having 
direct correlation with low-density lipoproteins, while the free thyroxine inversely correlated with 
total cholesterol, low-density lipoproteins and high-density lipoproteins, and free triiodothyronine 
negatively correlated with high-density lipoproteins. Our observations coincide with the research 
by Demellawy E. I. et al., which was based on studying the relationship between lipid metabolism 
and insulin sensitivity in hyperthyroidism and demonstrated the positive correlation between HDL, 
LDL levels, HOMA-IR indices and thyroid hormones (FТ3 і FТ4) [19].
Fasting glucose directly correlated with HbA1c, НОМА-IR, insulin and inversely correlat-
ed with HDL. Unidirectional correlations between HbA1c and blood glucose (р<0,05) have been 
found out. It means that HbA1c is a summary index of the average glucose level over the previous 
2–3 months. So, HbA1c also directly correlated with glucose, НОМА-IR and inversely correlated 
with the free cholesterol, HDL. The insulin level directly correlated with FТ4, FТ3, glucose, HbA1c, 
and inversely correlated with HDL. Described observations prove the opinions of other authors, who 
found out the positive correlation between insulin and вТ4 in patients with Graves’ disease [20].
The further scientific researches will be focused on the study of clinical and pathogenetic 
correlation between IR indices and Graves’ disease, as well as on the ways of IR correction in 
thyroid disorders.
6. Conclusions
The research determined that the insulin level is directly correlated with free thyroxine and 
free triiodothyronine in patients with Graves’ disease. HbA1c directly correlated with НОМА-IR in-
dex and inversely correlated with НОМА-β. НОМА-IR index and Caro index correlated inversely.
While determining the correlations between indices, we noted low direct correlation be-
tween C-peptide and triglycerides that had not been noticed before.
The study proves the presence of insulin resistance in patients with Graves’ disease that 
generates interest to further study of the changes in insulin sensitivity, relation of insulin resis-
tance to thyroid-stimulating hormone, thyroid hormones and looking for the ways to correct these 
disorders.
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